ZA879403B - Primary biliary cirrhosis autoantigen - Google Patents

Primary biliary cirrhosis autoantigen

Info

Publication number
ZA879403B
ZA879403B ZA879403A ZA879403A ZA879403B ZA 879403 B ZA879403 B ZA 879403B ZA 879403 A ZA879403 A ZA 879403A ZA 879403 A ZA879403 A ZA 879403A ZA 879403 B ZA879403 B ZA 879403B
Authority
ZA
South Africa
Prior art keywords
biliary cirrhosis
primary biliary
autoantigen
polypeptides
peptides
Prior art date
Application number
ZA879403A
Other languages
English (en)
Inventor
Leon Coppel Ross
Eric Gershwin Merrill
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Publication of ZA879403B publication Critical patent/ZA879403B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA879403A 1986-12-16 1987-12-15 Primary biliary cirrhosis autoantigen ZA879403B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPH952386 1986-12-16

Publications (1)

Publication Number Publication Date
ZA879403B true ZA879403B (en) 1988-06-23

Family

ID=3771952

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879403A ZA879403B (en) 1986-12-16 1987-12-15 Primary biliary cirrhosis autoantigen

Country Status (10)

Country Link
US (2) US5196319A (xx)
EP (1) EP0293471B1 (xx)
JP (3) JP2815582B2 (xx)
AT (1) ATE139259T1 (xx)
AU (1) AU604087B2 (xx)
CA (1) CA1341231C (xx)
DE (1) DE3751834T2 (xx)
NZ (1) NZ222942A (xx)
WO (1) WO1988004689A1 (xx)
ZA (1) ZA879403B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395753A (en) * 1993-02-19 1995-03-07 Theratech, Inc. Method for diagnosing rheumatoid arthritis
WO1995033476A1 (en) * 1994-06-03 1995-12-14 St. Luke's-Roosevelt Hospital Center A PURIFIED 80 kDa PROTEIN IMPLICATED IN ABDOMINAL AORTIC ANEURYSMS, ANTIBODIES DIRECTED THERETO, AND USES THEREOF
US6048704A (en) * 1996-03-07 2000-04-11 The Trustees Of Columbia University Purified and recombinant antigenic protein associated with abdominal aortic aneurysm (AAA) disease, and diagnostic and therapeutic use thereof
CA2256684A1 (en) * 1996-06-24 1997-12-31 Patrick Leung Recombinant fusion protein comprising pdc-e2, bcoadc-e2, and ogdc-e2 and uses thereof
DE19805815C1 (de) 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
GB0000992D0 (en) * 2000-01-18 2000-03-08 Astrazeneca Uk Ltd Methods
AU2002254431A1 (en) * 2001-03-27 2002-10-08 M. Eric Gershwin Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
CA2965189C (en) 2009-10-05 2020-06-30 Ambergen, Inc. A method for diagnosing primary biliary cirrhosis (pbc) using novel autoantigens
CN104292322A (zh) * 2012-03-23 2015-01-21 中国医学科学院北京协和医院 原发性胆汁性肝硬化特异性自身抗原及其应用

Also Published As

Publication number Publication date
DE3751834T2 (de) 1996-11-07
NZ222942A (en) 1991-06-25
ATE139259T1 (de) 1996-06-15
US5891436A (en) 1999-04-06
EP0293471B1 (en) 1996-06-12
JP2815582B2 (ja) 1998-10-27
AU604087B2 (en) 1990-12-06
US5196319A (en) 1993-03-23
DE3751834D1 (de) 1996-07-18
CA1341231C (en) 2001-05-15
WO1988004689A1 (en) 1988-06-30
EP0293471A1 (en) 1988-12-07
JP2875226B2 (ja) 1999-03-31
JPH01502077A (ja) 1989-07-27
JPH1175864A (ja) 1999-03-23
EP0293471A4 (en) 1990-05-14
JPH09308490A (ja) 1997-12-02
AU1086888A (en) 1988-07-15

Similar Documents

Publication Publication Date Title
MY102505A (en) Novel osteoinductive factors.
GB2303855B (en) Helicobacter pylori antigenic protein preparation and immunoassays
DE69431060T2 (de) Klonierte glutaminsäure-decarboxylase
GR3005447T3 (xx)
EP0269712A4 (en) PEPTIDES INVOLVED IN THE PATHOGENESIS OF A HIV TYPE INFECTION.
NZ224046A (en) Hiv antigenic peptide fragments and their use
GR77437B (xx)
EP0196319A4 (en) RETROVIRAL POLYPEPTIDES ASSOCIATED WITH THE TRANSFORMATION OF HUMAN CELLS.
DK143492A (da) Human-h2-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet
ZA879403B (en) Primary biliary cirrhosis autoantigen
DE3579148D1 (de) Polypeptid und polypeptidzusammensetzung.
ZA905927B (en) Biological preparation and its use
OA09233A (en) Permanent waving process and compositions.
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
ES2012997A6 (es) Un procedimiento para la obtencion de una linea de celulas hibridas que producen un anticuerpo monoclonal.
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
DE3268716D1 (en) Peptides and process for their preparation
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
NZ224313A (en) Hetero-ring condensed quinolineamines and pharmaceutical compositions
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
Henry The sources of self-esteem in six native adults
AU2715288A (en) Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein
GB9013872D0 (en) Use of protein a and polypeptide components thereof in the treatment of tumours
NZ333652A (en) Inhibition of human rotavirus infection using kappa-casein